HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 19 Aug 2026
Showing 10 of 27 filings.
19 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper publication of Notice of 41st AGM through Video Conferencing (''''VC'''')/ Other Audio Visual Means (''''OAVM'''')

Filed 16:28View Source
12 Aug 20261 filing
Company UpdateNewspaper Publication

Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015

Filed 12:42View Source
11 Aug 20262 filings
Company UpdateChange in Management

Biofil approves continuation of Ashok Ramawat as Non-Executive Independent Director subject to shareholder approval

Director continuation

  • Change type: Continuation of Non-Executive Independent Director.
  • Name and designation: Ashok Kumar Ramawat, Non-Executive Independent Director.
  • Reason: continuation despite age 75 under Regulation 17(1A).
  • Effective/term: continuation approved subject to Special Resolution at the 41st AGM.
  • Original appointment: 25 August 2020.
  • Profile: Bachelors in Science; 46 years pharma experience.
  • Relationships: not related to any director or KMP.
  • Board meeting: held on 11 August 2026.
Filed 18:34View Source
Board MeetingOutcome of Board Meeting

Biofil approves unaudited Q1 FY2027 results; AGM Sept 23, 2026; Ramawat to continue as independent director.

Financial results

  • Un-audited standalone results for quarter ended 30 June 2026 approved.

Directorship continuity

  • Continues Mr. Ashok Kumar Ramawat as Non-Executive Independent Director on attaining 75 years.

Governance disclosures

  • Board approved Operation Report, Corporate Governance Report and MD&A for year ended 31 March 2026.

Shareholder meeting

  • 41st AGM scheduled for 23 September 2026 at 3:00 PM via VC/OAVM.

Manufacturing upgrade

  • Renovation/upgradation of manufacturing facility; completion expected in 3-6 months.

Auditor remarks

  • Independent Auditor's Review Report: no material misstatement detected.

Segment revenue

  • Total segment revenue 1,235.02 Lakhs for quarter ended 30 June 2026.

Outlook

  • Upgradation expected to enhance capacity and support future sales.
Filed 18:08View Source
1 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing, listing, and 15-day registration update

Dematerialisation processing and listing

  • Registrar & Transfer Agent confirmed processing of dematerialisation requests for the quarter.
  • Securities dematerialised have been listed on exchanges where the earlier issued securities are listed.
  • Physical certificates for dematerialisation were mutilated and cancelled; depository name substituted within 15 days.
Filed 16:28View Source
1 Jun 20261 filing
Company UpdateNewspaper Publication

Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015

Filed 12:20View Source
10 Apr 20261 filing
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Filed 12:44View Source
3 Apr 20261 filing
Company UpdateNewspaper Publication

Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities.

Filed 12:54View Source
24 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window period for the quarter and financial year ended 31.03.2026

Filed 15:35View Source
3 Feb 20261 filing
Company UpdateGeneral

Clarification on Price Movement

Filed 19:09View Source
Showing 10 of 27 filings